What's the right base-to-variable split for a CRO running a $50M ARR business?

Base $475k–$525k (55–60% of OTE), variable $325k–$425k (40–45%) at $850k–$950k OTE — plus $150k–$250k/yr equity vest (RSUs) and 0.10–0.25% fully diluted refresh — is the defensible 50/50-leaning split for a CRO running a $50M ARR private SaaS business in 2026. Anything more variable than 55/45 turns the CRO into a glorified VP Sales chasing Q4; anything more base-heavy than 65/35 erodes urgency and signals the board has lost leverage on revenue.

The split is not arbitrary — it tracks four converging benchmarks: Bridge Group's CRO Compensation Research (n=145+ senior sales leaders), Pavilion's 2025 GTM Compensation Report, Spencer Stuart / Carta equity benchmarks, and public 14A filings from late-stage SaaS comps like Snowflake (Chris Degnan ran a multibillion-ARR org on a $400k–$450k base / $400k–$468k target bonus structure per FY24/FY25 DEF 14A — a roughly 50/50 cash mix with the upside loaded into RSUs).

Why 55–60% Base at $50M ARR

A $50M ARR business is past founder-led sales, in the awkward post-Series C / pre-IPO band where the CRO must build durable systems, not chase whales. The job is 70% operating (territory design, quota setting, enablement, RevOps, CS handoffs, forecast hygiene) and 30% closing. Comp must reward the operating work or it won't get done.

• CRO output is measured quarterly, not deal-by-deal. Hiring, comp, territories, ramp, and coaching decisions take 60–90 days to register in ARR. Pay mix tied to monthly variable creates whiplash and bad shortcuts (pulled-forward billings, sandbagged quotas, AE churn).
• Retention math. Top operating CROs at $50M+ field 2–3 inbound calls per year from search firms (Spencer Stuart, Heidrick, True Search). Below ~$450k base, the CRO is one Tuesday call away from a Series C cash-rich offer at a faster grower. Base must feel protective.
• Stakeholder alignment. Board wants the CRO to own the *machine* — pipeline coverage, productivity per AE, NRR — not just the rainmaker scoreboard. A 55–60% base says "you own the system"; a 40/60 plan says "go close deals."

OTE Benchmarks by Stage (2026 data)

Sources: Pavilion 2025 Executive Compensation Report; Bridge Group CRO Compensation Research; Spencer Stuart late-stage SaaS exec comp benchmarks; Carta equity data; cross-checked against Snowflake DEF 14A (FY25), Confluent DEF 14A (FY24), Datadog DEF 14A (FY24).

The $50M CRO Comp Stack — Worked Example

1. Base salary: $475k (55% of OTE)
2. Annual cash incentive: $375k target (45% of OTE), paid quarterly with annual true-up
3. New-hire equity: 0.18% fully diluted, 4-year vest with 1-year cliff (≈ $900k–$1.8M paper value at $500M–$1B post-money)
4. Annual refresh equity: 0.04–0.06% FD starting year 2, 4-year vest
5. Sign-on: $150k–$300k cash to offset forfeited equity at prior employer (Snowflake offered $1.9M sign-on for its incoming CRO per the 2025 offer letter — that's the high end at scale)
6. SPIFFs / discretionary: $50k–$100k pool for board-priority outcomes (named-account logos, expansion into new ICP, M&A integration)

Variable Plan Mechanics — What the 45% Actually Pays For

Board-set MBO components, weighted:

• 50% — Net New ARR vs plan. Threshold 80% of plan = 0 payout; 100% = full; 120% = 1.4–1.6x accelerator (see /knowledge/q05 for accelerator design)
• 25% — Net Revenue Retention. Target 110%+ for SaaS (Iconiq/Bessemer benchmark). Below 100% = 0; 100–110% = 50%; 110%+ = full
• 15% — Sales Efficiency / Magic Number. Target ≥ 0.7 on a TTM basis; this is the "did you grow ARR without burning cash" gate
• 10% — Strategic MBOs. Board-set: GTM motion launch, channel program, segment entry, hiring milestones

Quarterly cadence with annual reconciliation prevents single-quarter optimization. No commission on individual deals — that's a VP Sales plan, not a CRO plan (see /knowledge/q01 for AE OTE design and /knowledge/q02 for SDR plan design).

Equity Is Where the Real Money Lives

At $50M ARR, expect:

• 0.10–0.25% fully diluted for new-hire grant (Spencer Stuart / Carta benchmark, 2026)
• 4-year vest, 1-year cliff, then monthly — standard. Some boards push 25/25/25/25 annual to slow walk-away risk
• Refresh grants of 0.04–0.06% FD starting year 2 to keep total unvested equity at roughly 1x base
• Double-trigger acceleration on change of control (CIC + termination without cause) — non-negotiable for a serious CRO
• At a $500M post-money, 0.18% = $900k paper. At $1B (typical for $50M ARR @ 15–20x ARR multiple in 2026), it's $1.8M. At a 3x exit, it's $2.7M–$5.4M. This dwarfs the cash bonus and is the actual retention tool.

Public-Comp Reality Check (DEF 14A data)

• Snowflake (Chris Degnan, CRO through March 2025): $400k–$450k base, ~$400k–$468k target/actual non-equity incentive, $10M–$15M annual stock awards. Even at multibillion-ARR scale, the cash side stays disciplined; equity is the real upside. (DEF 14A FY24 and FY25)
• Snowflake's incoming CRO (Mike Gannon, 2025): $1.9M sign-on, base + bonus mix consistent with predecessor, fresh RSU grant in the eight-figure range
• Confluent (CRO Erica Schultz historically): roughly 50/50 cash mix, equity-loaded
• Datadog: discloses CRO-equivalent comp through go-to-market EVP roles with similar structure — modest base relative to scale, RSU-heavy

These tell you: at scale, cash discipline holds; equity does the heavy lifting. A $50M private CRO should not expect to out-earn the cash side of a $5B ARR public-comp CRO. The lever is equity %.

Bear Case — When 55/45 Is Wrong

The 50/50-leaning split assumes a "normal" enterprise SaaS motion. Three legitimate exceptions:

1. Founder-CEO still leads sales (founder-led sales): If the founder owns the top 20 logos and the "CRO" is really a head of sales operations + mid-market closer, pay it like a VP Sales: 60/40 or even 65/35 *variable* with deal-level commission below a threshold ACV. OTE drops to $400k–$600k. Don't pay CRO comp for a non-CRO job.
2. PE-backed roll-up at $50M ARR (PE-backed CRO): PE owners typically push toward higher variable (45–50%) tied to EBITDA, not just ARR, plus MIP (management incentive plan) equity worth 1–3% of equity value at exit. Cash base often *lower* ($350k–$425k), with the carrot being the 3–5 year exit MIP. Per Pavilion's Q1 2026 data, PE-backed shops in the $50M–$150M ARR band are creating the CRO title for the first time and anchoring offers below VC-backed comps.
3. PLG-dominant / regulated / government verticals: PLG companies where >60% of ARR comes through self-serve should pay the CRO closer to 65/35 base-heavy because the CRO's job is conversion mechanics and expansion, not closing — variable below 35% is correct (OpenView/Pocus framework). Government/regulated SaaS (FedRAMP, HIPAA-heavy) has 12–24 month sales cycles that make annual variable a coin flip; lengthen measurement window and bias to base.

Red Flags (Hire/Don't-Hire Signals)

• Below $400k base at $50M ARR → CRO leaves inside 24 months, full stop
• Above 50% variable with monthly payout → metric gaming, sandbagged forecasts, end-of-quarter discount disasters
• No equity refresh language in offer → year 3 retention cliff guaranteed
• No double-trigger CIC acceleration → CRO will block or slow-walk an acquisition to protect unvested equity
• Quota-to-OTE leverage above 6x → plan is unattainable; CRO will renegotiate or leave (Bridge Group median is 4.2x for AEs; CRO leverage should land 5–8x of OTE against new-ARR target)

Cross-References

• /knowledge/q01 — Enterprise AE OTE for $100k+ ACV deals
• /knowledge/q02 — SDR commission design that resists MQL gaming
• /knowledge/q04 — Ramp comp that doesn't punish first-90-day reps
• /knowledge/q05 — Accelerator multiples past 100% of quota
• /knowledge/q06 — Capping vs uncapping commission for top performers

TAGS: comp,cro,executive,series-c,base-variable,ote,equity,def-14a,pavilion,bridge-group

Sanity-Check Math: Why $475k base / $375k variable Pencils Out at $50M ARR

A $50M ARR business growing 30% YoY adds ~$15M new ARR. Total fully-loaded sales & marketing cost typically lands at 40–55% of new ARR (Iconiq State of Cloud benchmark). On $15M new ARR that's $6M–$8.25M in S&M spend. The CRO's all-in cost (cash + amortized equity) at ~$1.0M–$1.2M is 12–16% of the S&M envelope — defensible. If the CRO line item exceeds 20% of S&M, the comp plan is over-indexed for the company's stage and the board should re-baseline.

Plan Documents the Board Should Insist On

Before the offer letter is signed, the board comp committee should approve a written CRO Comp Plan covering: (1) measurement methodology — how Net New ARR is recognized (booked vs. starting MRR), how NRR is computed and against which cohort, how Magic Number is calculated; (2) claw-back terms — minimum 12-month recoupment on bonus paid against ARR that subsequently churns inside the period; (3) dispute resolution — board comp committee chair as first-tier arbiter, not the CEO; (4) change-of-control treatment — double-trigger acceleration on all unvested equity with a 12-month tail; (5) PIP framework — written 90-day improvement plan with explicit metrics before any "for cause" termination, since CRO turnover at $50M+ averages 18–22 months per Pavilion's 2025 data and most boards mishandle the exit.

Quick Decision Framework (Use This in the Offer)

If you are a founder/CEO or board member designing this offer right now:

1. Anchor base at 55% of the OTE band for your stage (table above). If you're at the high end of $50M ARR (e.g., $80M+), use 58–60%.
2. Set OTE leverage at 5–7x the CRO's annual ARR plan number (so a $15M new-ARR plan implies $75M–$105M of leverage envelope, comfortably covering the $375k variable).
3. Equity grant: 0.18% FD as the anchor, with 0.10% as the floor for an internal promote and 0.25% as the ceiling for a marquee external hire from a public-comp competitor.
4. Refresh language must be explicit — "annual top-up grants targeting 1x base in unvested equity at any time" — or the year 3 retention cliff is unavoidable.
5. Bonus payout cadence: quarterly with annual true-up, not monthly. Monthly variable for a CRO is malpractice at $50M ARR.
6. Run the plan past a third party (Pavilion benchmark dataset, Compensia, or your law firm's exec comp practice) before the offer goes out. The cost is $5k–$25k; the cost of a bad CRO offer is 18 months of stalled growth.

This is the playbook. The exact numbers flex with geography (NYC/SF +10–15%), industry (security/data infra +5–10%, horizontal SaaS baseline, vertical SaaS -5–10%), and motion (enterprise-only +5%, hybrid baseline, PLG -5–10%). Use the table, then adjust.